Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Arthur

Showing results (241-250 of 411) with videos related to

Pageof 42
Sort By:
North Carolina Medical Journal|November 1, 1992
Successful laparoscopic management of perforated gallbladder associated with Salmonella javiana infectionJ G Lee, M E McLeod, W C Meyers, et al.
Toxicology Reports|September 30, 2017
Toxicological evaluation of a novel umami flavour compound: 2-(((3-(2,3-Dimethoxyphenyl)-1<i>H</i>-1,2,4-triazol-5-yl)thio)methyl)pyridineDonald S Karanewsky, Amy J Arthur, Hanghui Liu, et al.
Toxicology Reports|September 30, 2017
Toxicological evaluation of two novel bitter modifying flavour compounds: 3-(1-((3,5-dimethylisoxazol-4-yl)methyl)-1<i>H</i>-pyrazol-4-yl)-1-(3-hydroxybenzyl)imidazolidine-2,4-dione and 3-(1-((3,5-dimethylisoxazol-4-yl)methyl)-1<i>H</i>-pyrazol-4-yl)-1-(3-hydroxybenzyl)-5,5-dimethylimidazolidine-2,4-dioneDonald S Karanewsky, Amy J Arthur, Hanghui Liu, et al.
Rapid Communications in Mass Spectrometry : RCM|October 19, 2021
Chemometric approaches to resolving base oil mixturesSamuel Ellick, Christianne Wicking, Thomas Hancock, et al.
Journal of Cardiovascular Risk|August 1, 1994
The prevalence of ST-segment depression on ambulatory electrocardiographic monitoring during daily life in high-risk asymptomatic police officersM A Arstall, R D Wuttke, J Arthur, et al.
The Journal of Clinical Investigation|July 1, 1992
Human hepatic lipocytes synthesize tissue inhibitor of metalloproteinases-1. Implications for regulation of matrix degradation in liverJ P Iredale, G Murphy, R M Hembry, et al.
The Physician and Sportsmedicine|December 20, 2017
lettersRichard W Redfearn, Larry J Leverenz, Robert L Kaman, et al.
Journal of Pediatric Surgery|September 1, 1996
Enteric fistulas and necrotizing enterocolitisM D Stringer, E Cave, J W Puntis, et al.
Gastroenterology|March 1, 1996
Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liverR C Benyon, J P Iredale, S Goddard, et al.
Journal of Biochemical and Biophysical Methods|July 2, 2003
An evaluation of protein assays for quantitative determination of drugsKatherine M Williams, Sarah J Arthur, Gillian Burrell, et al.
Pageof 42

Showing results (241-250 of 411) with videos related to

Sort By:
Pageof 42
North Carolina Medical Journal|November 1, 1992
Successful laparoscopic management of perforated gallbladder associated with Salmonella javiana infectionJ G Lee, M E McLeod, W C Meyers, et al.
Toxicology Reports|September 30, 2017
Toxicological evaluation of a novel umami flavour compound: 2-(((3-(2,3-Dimethoxyphenyl)-1<i>H</i>-1,2,4-triazol-5-yl)thio)methyl)pyridineDonald S Karanewsky, Amy J Arthur, Hanghui Liu, et al.
Toxicology Reports|September 30, 2017
Toxicological evaluation of two novel bitter modifying flavour compounds: 3-(1-((3,5-dimethylisoxazol-4-yl)methyl)-1<i>H</i>-pyrazol-4-yl)-1-(3-hydroxybenzyl)imidazolidine-2,4-dione and 3-(1-((3,5-dimethylisoxazol-4-yl)methyl)-1<i>H</i>-pyrazol-4-yl)-1-(3-hydroxybenzyl)-5,5-dimethylimidazolidine-2,4-dioneDonald S Karanewsky, Amy J Arthur, Hanghui Liu, et al.
Rapid Communications in Mass Spectrometry : RCM|October 19, 2021
Chemometric approaches to resolving base oil mixturesSamuel Ellick, Christianne Wicking, Thomas Hancock, et al.
Journal of Cardiovascular Risk|August 1, 1994
The prevalence of ST-segment depression on ambulatory electrocardiographic monitoring during daily life in high-risk asymptomatic police officersM A Arstall, R D Wuttke, J Arthur, et al.
The Journal of Clinical Investigation|July 1, 1992
Human hepatic lipocytes synthesize tissue inhibitor of metalloproteinases-1. Implications for regulation of matrix degradation in liverJ P Iredale, G Murphy, R M Hembry, et al.
The Physician and Sportsmedicine|December 20, 2017
lettersRichard W Redfearn, Larry J Leverenz, Robert L Kaman, et al.
Journal of Pediatric Surgery|September 1, 1996
Enteric fistulas and necrotizing enterocolitisM D Stringer, E Cave, J W Puntis, et al.
Gastroenterology|March 1, 1996
Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liverR C Benyon, J P Iredale, S Goddard, et al.
Journal of Biochemical and Biophysical Methods|July 2, 2003
An evaluation of protein assays for quantitative determination of drugsKatherine M Williams, Sarah J Arthur, Gillian Burrell, et al.
Pageof 42